Is it possible to predict, whether BAL salvage is going to be diagnostic?


Journal

Advances in respiratory medicine
ISSN: 2543-6031
Titre abrégé: Adv Respir Med
Pays: Switzerland
ID NLM: 101697329

Informations de publication

Date de publication:
2019
Historique:
received: 20 12 2018
accepted: 05 02 2019
revised: 30 01 2019
pubmed: 5 3 2019
medline: 7 2 2020
entrez: 5 3 2019
Statut: ppublish

Résumé

Bronchoalveolar lavage (BAL) is used in the diagnosis of interstitial lung diseases. BAL is diagnostic when ≥ 60% of the instilled volume is recovered. There are no reliable markers useful to predict whether BAL volume is going to be diagnostic. Our goal was to search for pulmonary function markers which could anticipate whether the recovered volume of instilled fluid would be ≥ 60% of administered volume. BAL volumes and quality were analyzed in the context of disease, medical condition and lung function test results of the subjects hospitalized at the Pulmonology Ward from January 2015 to October 2016. The patients' average age was 61 (29-89). Among 80 procedures, diagnostic BAL (≥ 60%) has been obtained in 58 cases. The analysis of the group of patients with an interstitial lung disease confirmed that there is a correlation between decreasing BAL recovered volume and an increase of RV[%pred] (r = -0.34) and RV/TLC[%pred] (r = -0.41); p < 0.05. There was no significant correlation with DLCO. RV/TLC[%pred] was the parameter with the highest predictive value for an anticipated correct BAL recovery. The curve analysis of the receiver operating characteristic (ROC) showed a diagnostic accuracy (AUC 0.73, 95% CI 0.61-0.86). Pulmonary hyperinflation may have a predictive role in anticipating a proper recovery of the BAL fluid volume.

Identifiants

pubmed: 30830956
pii: VM/OJS/J/62290
doi: 10.5603/ARM.a2019.0004
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-25

Auteurs

Szymon Skoczyński (S)

Department of Pneumonology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Poland. simon.mds@poczta.fm.

Ewelina Tobiczyk (E)

Department of Pneumonology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Poland.

Łukasz Minarowski (Ł)

2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Poland.

Marta Świerczyńska (M)

Department of Pneumonology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Poland.

Robert Mróz (R)

2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Poland.

Adam Barczyk (A)

Department of Pneumonology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH